“Metabolome-Wide Association Study of Neovascular Age-Related Macular Degeneration,” by Melissa P. Osborn, Youngja Park, Megan B. Parks, L. Goodwin Burgess, Karan Uppal, Kichun Lee, Dean P. Jones, and Milam A. Brantley Jr. (PLoS ONE 8(8): e72737. doi:10.1371/journal.pone.0072737, XML, HTML, and .pdf format, 10p.).
www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0072737
A. “Elevated Alpha-Synuclein Impairs Innate Immune Cell Function and Provides a Potential Peripheral Biomarker for Parkinson’s Disease,” by Shyra J. Gardai, Wenxian Mao, Birgitt Schüle, Michael Babcock, Sue Schoebel, Carlos Lorenzana, Jeff Alexander, Sam Kim, Heather Glick, Kathryn Hilton, J. Kent Fitzgerald, Manuel Buttini, San-San Chiou, Lisa McConlogue, John P. Anderson, Dale B. Schenk, Frederique Bard, J. William Langston, Ted Yednock, and Jennifer A. Johnston (PLoS ONE 8(8): e71634. doi:10.1371/journal.pone.0071634, XML, HTML, and .pdf format, 21p.).
www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0071634
B. “Phototoxic Action Spectrum on a Retinal Pigment Epithelium Model of Age-Related Macular Degeneration Exposed to Sunlight Normalized Conditions,” by Emilie Arnault, Coralie Barrau, Celine Nanteau, Pauline Gondouin, Karine Bigot, Francoise Vienot, Emmanuel Gutman, Valerie Fontaine, Thierry Villette, Denis Cohen-Tannoudji, Jose-Alain Sahel, and Serge Picaud (PLoS ONE 8(8): e71398. doi:10.1371/journal.pone.0071398, XML, HTML, and .pdf format, 12p.).
www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0071398
A. “Circulating miRNA Biomarkers for Alzheimer’s Disease,” by Pavan Kumar, Zoltan Dezso, Crystal MacKenzie, Judy Oestreicher, Sergei Agoulnik, Michael Byrne, Francois Bernier, Mamoru Yanagimachi, Ken Aoshima, and Yoshiya Oda (PLoS ONE 8(7): e69807. doi:10.1371/journal.pone.0069807, XML, HTML, and .pdf format, 10p.).
www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0069807
B. “The Association between Plasma 25-Hydroxyvitamin D and Subgroups in Age-Related Macular Degeneration: A Cross-Sectional Study,” by Amardeep Singh, Mads Kruger Falk, Yousif Subhi, and Torben Lykke Sorensen (PLoS ONE 8(7): e70948. doi:10.1371/journal.pone.0070948, XML, HTML, and .pdf format, 9p.).
www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0070948
C. “Drawing to Remember: External Support of Older Adults’ Eyewitness Performance,” by Coral J. Dando (PLoS ONE 8(7): e69937. doi:10.1371/journal.pone.0069937, XML, HTML, and .pdf format, 8p.).
www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0069937
“Interaction of Complement Factor H and Fibulin3 in Age-Related Macular Degeneration,” by M. Keith Wyatt, Jen-Yue Tsai, Sanghamitra Mishra, Maria Campos, Cynthia Jaworski, Robert N. Fariss, Steven L. Bernstein, and Graeme Wistow (PLoS ONE 8(6): e68088. doi:10.1371/journal.pone.0068088, XML, HTML, and .pdf format, p.).
www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0068088
“Targeting cholesterol buildup in eye may slow age-related vision loss,” (April 3, 2013).
“Prevalence of Age-Related Macular Degeneration in Nakuru, Kenya: A Cross-Sectional Population-Based Study,” by Wanjiku Mathenge, Andrew Bastawrous, Tunde Peto, Irene Leung, Allen Foster, and Hannah Kuper (PLoS Med 10(2): e1001393. doi:10.1371/journal.pmed.1001393, XML, HTML, and .pdf format, 11p.).
www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1001393
“Interleukin 27 Induces the Expression of Complement Factor H (CFH) in the Retina,” by Ahjoku Amadi-Obi, Cheng-Rong Yu, Ivy Dambuza, Sung-Hye Kim, Bernadette Marrero, and Charles E. Egwuagu (PLoS ONE 7(9): e45801. doi:10.1371/journal.pone.0045801, XML, HTML, and .pdf format, 9p.).
www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0045801
A. “Complement factor H genotypes impact risk of age-related macular degeneration by interaction with oxidized phospholipids,” by Peter X. Shaw, Li Zhang, Ming Zhang, Hongjun Du, Ling Zhao, Clara Lee, Seanna Grob, Siok Lam Lim, Guy Hughes, Janet Lee, Matthew Bedell, Mark H. Nelson, Fang Lu, Martin Krupa, Jing Luo, Hong Ouyang, Zhidan Tu, Zhiguang Su, Jin Zhu, Xinran Wei, Zishan Feng, Yaou Duan, Zhenglin Yang, Henry Ferreyra, Dirk-Uwe Bartsch, Igor Kozak, Liangfang Zhang, Feng Lin, Hui Sun, Hong Feng, and Kang Zhang (Vol. 109, No. 34, Aug. 21, 2012, p. 13757-13762).
www.pnas.org/content/109/34/13757.abstract
B. “ERK1/2 activation is a therapeutic target in age-related macular degeneration,” by Sami Dridi, Yoshio Hirano, Valeria Tarallo, Younghee Kim, Benjamin J. Fowler, Balamurali K. Ambati, Sasha Bogdanovich, Vince A. Chiodo, William W. Hauswirth, Jennifer F. Kugel, James A. Goodrich, Steven L. Ponicsan, David R. Hinton, Mark E. Kleinman, Judit Z. Baffi, Bradley D. Gelfand, and Jayakrishna Ambati (Vol. 109, No. 34, Aug. 21, 2012, p. 13781-13786).
www.pnas.org/content/109/34/13781.abstract
C. “Postsynaptic dysfunction is associated with spatial and object recognition memory loss in a natural model of Alzheimer’s disease,” by Álvaro O. Ardiles, Cheril C. Tapia-Rojas, Madhuchhanda Mandal, Frédéric Alexandre, Alfredo Kirkwood, Nibaldo C. Inestrosa, and Adrian G. Palacios (Vol. 109, No. 34, Aug. 21, 2012, p. 13835-13840).
American Journal of Epidemiology (Vol. 176, No. 4, Aug. 15, 2012).
aje.oxfordjournals.org/content/176/4.toc?etoc
Archives of Gerontology and Geriatrics (Vol. 55, No. 2, September/October 2012).
www.sciencedirect.com/science/journal/01674943
Journal of the American Geriatrics Society (Vol. 60, No. 8, August 2012).
onlinelibrary.wiley.com/doi/10.1111/jgs.2012.60.issue-8/issuetoc
“NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components,” by Sarah L. Doyle, Matthew Campbell, Ema Ozaki, Robert G. Salomon, Andres Mori, Paul F. Kenna, Gwyneth Jane Farrar, Anna-Sophia Kiang, Marian M. Humphries, Ed C. Lavelle, Luke A. J. O’Neill, Joe G. Hollyfield & Peter Humphries (Vol. 18, No. 5, May 2012, p. 791-798).
Note: Lancet requires free registration before providing articles.
“Age-related macular degeneration,” by Laurence S. Lim, Paul Mitchell, Johanna M. Seddon, Frank G. Holz, and Tien Y. Wong (Vol. 379, No. 9827, May 5, 2012, p. 1728-1738).
www.lancet.com/journals/lancet/article/PIIS0140-6736%2812%2960282-7/abstract
“Avastin and Lucentis are equivalent in treating age-related macular degeneration,” (April 30, 2012).
“Medicare Payments for Drugs Used To Treat Wet Age Related Macular Degeneration,” (OEI-03-10-00360, April 2012, .pdf format, 18p.).
Note: Lancet requires free registration before providing content. “Embryonic stem cell trials for macular degeneration: a preliminary report,” by Steven D Schwartz, Jean-Pierre Hubschman, Gad Heilwell, Valentina Franco-Cardenas, Carolyn K Pan, Rosaleen M Ostrick, Edmund Mickunas, Roger Gay, Irina Klimanskaya, and Robert Lanza (Vol. 379, No. 9817, February 25, 2012, p. 713-720).
www.thelancet.com/journals/lancet/article/PIIS0140-6736%2812%2960028-2/abstract
Powered by WordPress
